ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Adjuvant chemotherapy benefits on patients with elevated carcinoembryonic antigen in stage IIA colon cancer: a SEER-based analysis

Zhou, Huabin; Wang, Songsheng; Cai, Zhai; Qiu, Enming; Chen, Qianyun; Rao, Xi; Han, Shuai; Li, Zhou*南方医科大学
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE2022-12DOI: 10.1007/s00384-022-04278-5
13阅读
引用收藏
分享

摘要

Objective Indications for adjuvant chemotherapy in stage IIA (T3N0M0) colon cancer are still controversial. The purpose of this study was to evaluate the prognostic value of elevated carcinoembryonic antigen (CEA) levels for cancer-specific survival (CSS) and overall survival (OS) in patients with stage IIA colon cancer. We aimed to examine the impact of adjuvant chemotherapy on OS in stage IIA colon cancer patients with elevated CEA levels. Methods Patients with stage IIA colon cancer (N = 3477) diagnosed between 2010 and 2015 were identified using the Surveillance, Epidemiology, and End Results (SEER) database. Kaplan-Meier and Cox proportional hazards regression models were used to assess the prognostic effect of CEA on CSS and OS. Results Cox regression analysis demonstrated that CEA was an independent risk factor for CSS and OS in patients with stage IIA colon cancer (CSS: HR = 2.001, 95% CI 1.603-2.499, P < 0.001; OS: HR = 1.530, 95% CI 1.335-1.752, P < 0.001). In the subgroup with elevated CEA, patients received adjuvant chemotherapy had a better OS compared with those did not (chi(2) = 10.585, p = 0.001). Conclusion CEA was an independent risk factor for CSS and OS in patients with stage IIA colon cancer. Patients with stage IIA colon cancer with an elevated CEA level might benefit from adjuvant chemotherapy.

学科与关键词

关键词
Carcinoembryonic antigenAdjuvant chemotherapyStage IIAColon cancerSEER
相关
加载中…
  • Early Postoperative Serum Carcinoembryonic Antigen Is a Stronger Independent Prognostic Factor for Stage II Colorectal Cancer Patients Than T4 Stage and Preoperative CEA
    Fenqi, Du; Yupeng, Liu; Qiuju, Zhang; Chao, Yuan; Wenjie, Song; Tianyi, Xia; Junnan, Guo; Weinan, Xue; Xiufeng, Jiang; Junge, Bai; Chenyang, Jia; Hua, Xi; Yien, Li; Xuefeng, Bai; Yanlong, LiuFrontiers in Oncology, 2022, 11: 758509.被引 8
  • Association of chemotherapy with survival in stage II colon cancer patients who received radical surgery: a retrospective cohort study
    Lv, Zhihao*; Liang, Yuqi; Liu, Huaxi; Mo, DelongBMC CANCER, 2021, 21(1): 306.被引 10
  • Dynamic monitoring of serum CEA and CA19-9 predicts the prognosis of postoperative stage II colon cancer
    Wang, Ren; Xu, Benjie; Sun, Mingming; Pang, Xiangyi; Wang, Xin; Zhu, Jiahao; Lian, Jie*; Lu, Haibo*EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 2023, 49(12): 107138.
查看全部 →

发表信息

论文状态
公开发表
期刊
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
发表日期
2022-12
卷期
第 37 卷, 第 12 期
页码
2481-2489
DOI
10.1007/s00384-022-04278-5
语言
ENGLISH
期刊等级
3区
成果收录
SCIE

作者

  • Z

    Zhou, Huabin (第一作者)

    southern med univ

  • W

    Wang, Songsheng

    southern med univ

查看全部 8 位作者收起作者
  • C

    Cai, Zhai

    southern med univ

  • Q

    Qiu, Enming

    southern med univ

  • C

    Chen, Qianyun

    southern med univ

  • R

    Rao, Xi

    southern med univ

  • H

    Han, Shuai

    southern med univ

  • L

    Li, Zhou (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417